Gege Tan

Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia

Andreas Varkaris, Ermira Pazolli, Hakan Günaydin et al. · Cancer Discovery · 2023 · 80 citations · Full text

Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages

Bryan D. Smith, Michael D. Kaufman, Scott Wise et al. · Molecular Cancer Therapeutics · 2021 · 65 citations · Full text

Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic

Jeffrey D. Kearns, Raghida A. Bukhalid, Mark Sevecka et al. · Molecular Cancer Therapeutics · 2015 · 55 citations

Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer

Adam J. Camblin, Emily A. Pace, Sharlene Adams et al. · Clinical Cancer Research · 2018 · 53 citations

Differences in Expression of Specific Biomarkers Distinguish Human Beard from Scalp Dermal Papilla Cells

Susan Rutberg, Meredith L. Kolpak, John A. Gourley et al. · Journal of Investigative Dermatology · 2006 · 51 citations · Full text

Cutaneous Biology, Pathology, Dermatology +4